Answer
Yes, upadacitinib hemihydrate is contraindicated in patients with severe hepatic impairment.
Sources for this answer
- RINVOQ 15 mg prolonged-release tabletsAbbVie Ltd · emc · SmPC §4.3 Contraindications · Version 28Document updated
Sources checked